Vertex Pharmaceuticals (NASDAQ: VRTX)
Vertex Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Vertex Pharmaceuticals Company Info
Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis.
News & Analysis
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
Vertex just laid claim to an asset that might be very valuable.
Vertex Pharmaceuticals: Buy, Sell, or Hold?
The stock hasn't made for a great buy this year, but is Vertex worth investing in for the long run?
This Growth Stock Is One Step Closer to Launching a New Blockbuster: Time to Buy?
This innovative machine rolls on.
Missed the "Magnificent Seven"? Try Buying These 3 Forever Stocks Instead
All three companies have very long runways for growth ahead.
1 Top Growth Stock to Buy and Hold Forever
This drugmaker looks unstoppable.
2 Rock-Solid Growth Stocks to Buy Right Now and Hold for at Least 5 Years
Great businesses are here to stay. These are two excellent examples.
3 Unstoppable Stocks to Buy Hand Over Fist in April
These stocks have exceptionally bright prospects.
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
It's always a good time to buy great stocks with excellent prospects.
Valuation
Podcast Episodes
Alleged Industrial Espionage Makes an Interesting Story
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
3 Biotech Companies Analyzed
We examine three biotech companies' past performances and future outlooks.
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Earnings Transcripts
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript
VRTX earnings call for the period ending December 31, 2023.
Vertex Pharmaceuticals (VRTX) Q3 2023 Earnings Call Transcript
VRTX earnings call for the period ending September 30, 2023.
Vertex Pharmaceuticals (VRTX) Q2 2023 Earnings Call Transcript
VRTX earnings call for the period ending June 30, 2023.
Vertex Pharmaceuticals (VRTX) Q1 2023 Earnings Call Transcript
VRTX earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.